Despite the impact of the ongoing COVID-19 pandemic, the Asia Pacific urological device market will continue to expand through 2029 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally invasive laser treatments for urinary stones and BPH will drive sales in several segments of this market, thus fueling overall market growth. However, the market will be negatively affected in the short term by the global COVID-19 pandemic.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in the Asia Pacific region across a 10-year period.
- Urological Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Hebri Nandita Mallya
Hebri Nandita Mallya is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in Diagnostic Imaging Systems market. Hebri Nandita Mallya holds a Bachelor's degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master's degree in Medical Biochemistry from Manipal Academy of Higher Education.